Clinical Trials Directory

Trials / Completed

CompletedNCT00987051

Sentinel Node and Endometrial Cancer

Validation of the Sentinel Node in Endometrial Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
133 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the relevance of sentinel node in endometrial cancer. Sentinel node is thought to reflect the status of lymph node. Only 10 to 20% of women with endometrial cancer exhibit lymph node metastasis hence systematic lymphadenectomy is questionable. In breast cancer, melanoma and vulvar cancer, sentinel node has emerged as an alternative to complete lymphadenectomy.

Detailed description

To investigate the relevance of sentinel node in endometrial cancer. Sentinel node is though to reflect the status of lymph node. Only 10 to 20% of women with endometrial cancer exhibit lymph node metastasis hence systematic lymphadenectomy is questionable. In breast cancer, melanoma and vulvar cancer, sentinel node has emerged as an alternative to complete lymphadenectomy. The objective of our trial is to validate the concept of sentinel node in endometrial cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREDetection of sentinel nodeCoelioscopy or laparotomy (based on the tumor size) after a colorimetric tracer injection

Timeline

Start date
2007-04-01
Primary completion
2009-12-01
Completion
2011-10-01
First posted
2009-09-30
Last updated
2012-12-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00987051. Inclusion in this directory is not an endorsement.